Status:
RECRUITING
Characterization of Cardiac Electrophysiological Effects of Autonomic Neuromodulation
Lead Sponsor:
University of Pennsylvania
Conditions:
Ventricular Tachycardia
Eligibility:
All Genders
18+ years
Phase:
EARLY_PHASE1
Brief Summary
Prospective cohort study evaluating the electrophysiologic and biochemical effects of stellate ganglion block in patients with ventricular tachycardia.
Eligibility Criteria
Inclusion
- Planned catheter based VT ablation
- Age at least 18 years
Exclusion
- Pregnancy
- Contraindication to SGB or VT ablation
- Hypersensitivity of local anesthetic of amide type
- Hemodynamic instability during the procedure prior to the study protocol
Key Trial Info
Start Date :
September 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2027
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05377216
Start Date
September 1 2022
End Date
July 1 2027
Last Update
November 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104